These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7201947)

  • 41. [Follow-up and second-look in epithelial carcinoma of the ovary].
    Carnino F; Guercio E; Cottini M; Gatti M
    Minerva Ginecol; 1984 Apr; 36(4):205-8. PubMed ID: 6235465
    [No Abstract]   [Full Text] [Related]  

  • 42. Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy?
    Linasmita V; Wilailak S; Thakkinstian A; Srisupundit S; Tangtrakul S; Israngura N; Bullangpoti S
    J Med Assoc Thai; 2001 Jul; 84(7):958-65. PubMed ID: 11759976
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience.
    Williams SD; Blessing JA; DiSaia PJ; Major FJ; Ball HG; Liao SY
    Gynecol Oncol; 1994 Mar; 52(3):287-91. PubMed ID: 8157184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The second look operation for carcinoma of the ovary.
    Wallach RC; Blinick G
    Surg Gynecol Obstet; 1970 Dec; 131(6):1085-9. PubMed ID: 4991336
    [No Abstract]   [Full Text] [Related]  

  • 45. [Second-look laparotomy in ovarian cancer].
    Piura B; Glezerman M
    Harefuah; 1987 Jan; 112(1):25-8. PubMed ID: 3301568
    [No Abstract]   [Full Text] [Related]  

  • 46. [The impact of the pathologist on the treatment of epithelial ovarial cancer].
    Zivanovic O; Braun M; Park TW; Kuhn W
    Verh Dtsch Ges Pathol; 2005; 89():101-10. PubMed ID: 18035679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ovarian cancer and the surgical knife. Advanced ovarian cancer].
    Bösze P
    Orv Hetil; 1993 Oct; 134(41):2243-8. PubMed ID: 8414467
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of neoadjuvant chemotherapy and interval laparotomy in advanced ovarian cancer.
    Huober J; Meyer A; Wagner U; Wallwiener D
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):153-60. PubMed ID: 11935302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Indications, standardization and therapeutic conclusions in second-look laparotomies in ovarian carcinoma].
    Engeler V; Kunz J; Schreiner WE
    Gynakol Rundsch; 1983; 23 Suppl 4():9-14. PubMed ID: 6674028
    [No Abstract]   [Full Text] [Related]  

  • 50. Second-look surgery (SLO) in the management of carcinoma of the ovary.
    Hernádi Z; Sápy T; Lukácskó L; Borsos A
    Acta Chir Hung; 1997; 36(1-4):128-9. PubMed ID: 9408314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current concepts in the management of ovarian carcinoma.
    Alberts DS
    Ariz Med; 1975 Dec; 32(12):951-4. PubMed ID: 1217990
    [No Abstract]   [Full Text] [Related]  

  • 52. The influence of initial residual disease on the outcome of second-look laparotomy in patients with carcinoma of the ovary.
    Soeters RP; Bloch B; Dehaeck K; Levin W
    Eur J Gynaecol Oncol; 1992; 13(3):223-7. PubMed ID: 1618220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medical treatment of epithelial ovarian cancer.
    González-Martín AJ
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1125-43. PubMed ID: 15606338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is there a role for consolidation or salvage radiotherapy after chemotherapy in advanced epithelial ovarian cancer?
    Thomas GM
    Gynecol Oncol; 1993 Oct; 51(1):97-103. PubMed ID: 8244182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [10 Year follow up of chemotherapy and surgery on the second laparotomy in advanced ovarian cancer].
    Ojeda B; Llanos M; Brunet J; Lacasta A; Alonso MC; Rueda A; Delgado E; Badía J; López López JJ
    Med Clin (Barc); 1995 Feb; 104(5):165-9. PubMed ID: 7877374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiotherapy as a cisplatin-sensitizer in a resistant ovarian carcinoma cell line.
    Siler DF; Wheeless CR; Dubin NH
    Cancer; 1996 May; 77(9):1850-3. PubMed ID: 8646684
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S; Yeap B; Vogl S; Carbone P
    Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A critical assessment of the role of second-look surgery in ovarian carcinoma.
    Runowicz CD
    Cancer Invest; 1987; 5(5):479-85. PubMed ID: 2962701
    [No Abstract]   [Full Text] [Related]  

  • 59. Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
    Littell RD; Hallonquist H; Matulonis U; Seiden MV; Berkowitz RS; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):570-4. PubMed ID: 16769104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cytoprotective effect of Amifostine in the combined chemotherapy of advanced ovarian carcinoma].
    Nagy P; Kádasi L
    Orv Hetil; 2000 Sep; 141(37):2027-30. PubMed ID: 11037611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.